Anavex Life Sciences logo

Anavex Life Sciences

AVXL | NASDAQ
Chart Builder DCF Calculator
$0.82
-$0.11 (-12.16%)
At close: Nov 16, 2026, 4:00 PM ET
$0.85
+$0.03 (+3.66%)
After-hours: Nov 16, 2026, 7:30 PM ET
-12.16%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 16, 2026
25.8
Fundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #908/1021 (Top 89%)

Key Statistics

Market Data

Market Cap $75.79M
1D Range
0.80 0.95
52W Range
0.80 5.30

Valuation (TTM)

PE -3.15
PB 0.67
EV/EBITDA 1.95

Valuation (NTM)

Forward PE 16.11
Forward PEG -0.10
Price Target $11.00
Loading financial charts...

Profile

Operating as a clinical-stage biopharmaceutical entity, Anavex Life Sciences Corp. specializes in developing therapeutic drug candidates for various central nervous system (CNS) conditions. Its leadin...

Sector Healthcare
Industry Biotechnology
Employees 34
IPO Date Aug 2, 2006
Fiscal Year October - September

Latest News

No news articles available yet.

Analyst Summary

# of Analysts
2
Consensus
Buy
Price Target
$11.00
Upside
+1241.46%
Buy (2)
Hold (0)
Sell (0)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.